Clinical Trial Update: Fosrenol and Phosphorus Balance - Lanthanum Carbonate [NA]

View source ↗

Summary

A completed clinical trial update reports on Fosrenol (lanthanum carbonate) and phosphorus balance in patients with chronic kidney disease, including end-stage …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Disorders Associated with Peritoneal Dialysis
• End-stage Renal Disease

Drugs mentioned

• FOSRENOL (lanthanum carbonate)

Snippet

Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Conditions: Chronic Kidney Failure, End-stage Renal Disease | NA | Status: COMPLETED